About trainings

The objective of the MPP is to support synergies between the medtech and pharma industries by establishing a forum to exchange knowledge and collaborate in the areas of technology and regulatory policy, while building stakeholder consensus to promote product development and innovation.

To this aim, the MPP dispenses accredited trainings throughout the year in addition to its annual meeting.

Target audience: Professionals and individuals in the medtech and pharma sectors.

Topics: The topics are varied, but broadly cover industry, regulatory and technical developments.

Course leaders: All trainings are given by topic experts.

Upcoming webinar

In einem Meeting

27 April 2021, 3:00-4:00 pm CEST /

2:00-3:00 pm GMT

Joint webinar MPP / UK Department for International Trade in Switzerland

Shayesteh Fürst-Ladani

SFL CEO and MPP President

Helen Stubbs, UK Department for International Trade in Switzerland

Senior Inward Investment Officer

Neil Ebenezer, UK Department for International Trade

Medtech Senior Specialist Advisor

Past training courses

In einem Meeting

16 February 2021

Virtual Training Course

Introduction to the EU MDR art. 117 and single integral drug/device combination products

Shayesteh Fürst-Ladani

SFL CEO and MPP President

Stephan Affolter, Ypsomed

Regulatory and Quality Intelligence Manager

Christiana Hofmann, TÜV-SÜD

Teamlead Non Active Medical Devices / Article 117 MDR

Mike Wallenstein, Novartis

Global Head MDR Implementation & DD&C Compliance

In einem Meeting

29 September 2020

Digital Training Course

Overview of Medical Devices Regulation
and Impacts on Combination Products

Stephan Affolter, Ypsomed

Regulatory and Quality Intelligence Manager

Karin Schulze, SFL

Head Medical Devices

Juan Martin Carriquiry, Novartis

EU MDR Expert